RecallRadar

FDA Drug recall D-0168-2023

Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: I…

On 2023-02-01 the FDA classified a Class II recall of Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: I… by Accord Healthcare, citing presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0168-2023
ClassificationClass II
Statusterminated
Initiated2023-01-12
Published2023-02-01
Last updated2026-09-13 11:52 UTC
CompanyAccord Healthcare
DistributionUS

Product

Allopurinol Tablets USP, 100 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. India. NDC 16729-134-01

Reason

Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Identifiers

ndc16729-134-10
ndc16729-134-01
ndc16729-134-16
ndc16729-134-17
ndc16729-135-10
ndc16729-135-01
ndc16729-135-16
ndc16729-135-17
code_infoLots: R2200455, R2200456 Exp. 03/2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0168-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.